The Biotinylated Anti-CD123 Antibody (HD1A006) is a valuable tool for research involving CD123, a cell surface marker commonly found on certain cancer cells, specifically leukemia cells. This antibody, conjugated with biotin for easy detection, is highly specific for human samples and is validated for use in a variety of applications, including immunofluorescence and flow cytometry.CD123, also known as interleukin-3 receptor alpha chain, is essential for the growth and survival of hematopoietic stem cells and is overexpressed on leukemia stem cells in various types of leukemia.
The ability to specifically target and detect CD123 makes this antibody ideal for use in studies related to leukemia, immunotherapy, and targeted cancer treatments.By accurately detecting and analyzing CD123 expression in cells, researchers can gain valuable insights into disease progression, treatment response, and potential therapeutic targets. The Biotinylated Anti-CD123 Antibody (HD1A006) is a powerful tool for advancing research in oncology and immunology, with the potential to impact the development of novel cancer therapies.
Purified from cell culture supernatant by affinity chromatography
Formulation:
Powder
Buffer:
1XPBS
Storage:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Usage:
Research use only
Background:
Interleukin 3 receptor alpha (low affinity) (IL3RA), also known as CD123 (Cluster of Differentiation 123) is a 70-kD glycoprotein member of the hematopoietin receptor superfamily. This protein associates with a beta subunit common to the receptors for IL-??
